Format

Send to

Choose Destination
Eur J Cancer. 2018 Mar;92:121-122. doi: 10.1016/j.ejca.2018.01.070. Epub 2018 Feb 9.

Response to Letter to the Editor, 'Pharmacokinetics partly explains the relationship between CEA level and survival of colorectal cancer patients treated with ramucirumab,' by Ibrahim et al.

Author information

1
National Cancer Center Hospital East, Chiba, Japan. Electronic address: tyoshino@east.ncc.go.jp.
2
Eli Lilly and Company, Bridgewater, NJ, USA.
3
Eli Lilly and Company, Buenos Aires, Argentina.
PMID:
29433790
DOI:
10.1016/j.ejca.2018.01.070
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center